Standout Papers
Immediate Impact
4 by Nobel laureates 32 from Science/Nature 118 standout
Citing Papers
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
2023 Standout
Site-selective modification strategies in antibody–drug conjugates
2020 Standout
Works of Thomas Chittenden being referenced
IMGN632: A CD123-Targeting Antibody-Drug Conjugate (ADC) with a Novel DNA-Alkylating Payload, Is Highly Active and Prolongs Survival in Acute Myeloid Leukemia (AML) Xenograft Models
2016
Antibody-Drug Conjugates Designed to Eradicate Tumors with Homogeneous and Heterogeneous Expression of the Target Antigen
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Thomas Chittenden | 1489 | 492 | 1819 | 704 | 24 | 3.4k | |
| Rama Modali | 2126 | 227 | 1739 | 603 | 26 | 4.0k | |
| P C Familletti | 977 | 593 | 1536 | 469 | 19 | 4.5k | |
| Mark Rolfe | 2439 | 189 | 4563 | 458 | 55 | 5.9k | |
| John P. McGrath | 2266 | 1000 | 4433 | 362 | 40 | 6.2k | |
| Yuval Reiss | 2196 | 215 | 4693 | 522 | 36 | 6.0k | |
| Antonia T. Destree | 837 | 235 | 2410 | 253 | 28 | 3.8k | |
| Erinna F. Lee | 1081 | 117 | 4333 | 605 | 73 | 5.4k | |
| Frank Podlaski | 3177 | 361 | 3778 | 502 | 26 | 7.1k | |
| Daisy Carvajal | 3041 | 207 | 3632 | 448 | 18 | 6.4k | |
| Leslie A. Goldstein | 688 | 158 | 1468 | 598 | 26 | 2.5k |
All Works
Login with ORCID to disown or claim papers
Loading papers...